Abstract: Monoclonal antibodies against sporozites of the Eimeria spp. are obtained by use of hybridoma technology. Specific sporozoite antigens for use as vaccines in the prevention and treatment of coccidiosis and hybridoma cultures producing monoclonal antibodies are described.
Type:
Grant
Filed:
March 19, 1984
Date of Patent:
December 1, 1987
Assignee:
American Cyanamid Company
Inventors:
Robert H. Schenkel, Rosie B. Wong, Pallaiah Thammana
Abstract: A process for producing an all natural, enzyme-saccharified, cereal derived from whole grain is disclosed. The process involves milling and separating the whole grain to produce a bran fraction, an endosperm fraction, and a germ fraction. The germ fraction is processed by toasting and grinding and preferably by removing bran before the toasting. The bran fraction and any bran material separated out from the ground germ is modified to increase its functionality by high temperature, high shear extrusion in a counter-rotating twin screw extruder. The endosperm fraction is coarsely milled, made into a slurry, cooked and then enzymatically hydrolyzed. The final step involves recombining the processed fractions, to form a cereal dough which is further processed to produce a ready-to-eat breakfast cereal. Optionally from 1-15% of the whole grain may be malted and added into the cereal dough.
Abstract: A new class of chemical reagents called release tags which comprise signal, release and reactivity groups is disclosed and a release tag involving a pentafluorobenzoyl signal group, a methionylamide release group, and an active ester reactivity group is used to analyze the hormone, thyroxine, in serum, involving quantitation of the released signal group by gas chromatography with electron capture detection.
Abstract: Peptidyl-glycine .alpha.-amidating monooxygenase is an enzyme extractable from medullary thyroid carcinoma cell lines and tissue samples, having a molecular mass of about 60,000 to 65,000 daltons. It has been purified so as to exhibit a single, homogeneous, well-defined band using electrophoretic procedures performed on SDS-polyacrylamide gels, and has a specific enzymatic activity of at least 50 mU per mg protein. The free or immobilized enzyme, in the presence of Cu.sup.+2 ions, ascorbate, and oxygen, can be used to prepare an .alpha.-amidated protein from a polypeptide substrate possessing a carboxyl-terminal glycine residue. The purified enzyme can be used as an antigen in order to produce enzyme-specific monoclonal antibodies, and can provide the information necessary to design and construct prokaryotes or other appropriate unicellular organisms or host cells isolated from multicellular organisms which possess peptidyl-glycine .alpha.-amidating capability.
Abstract: The present invention discloses isolated functionally intact whole genes and method of obtaining the same. The method includes treating genomic DNA with mung bean nuclease and formamide under controlled conditions. The invention also discloses cloning of said intact whole genes and a library of such cloned genes or any recombinations thereof. The invention is useful in deriving gene products as m-RNA, S-RNA, t-RNA, polypeptides and the like.
Type:
Grant
Filed:
July 31, 1984
Date of Patent:
November 17, 1987
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services
Abstract: A halogenation method using a haloperoxidase obtained from a fungus selected from the dematiaceous hyphomycetes. The enzyme has an optimum activity above about pH 5.0, and can oxidize chloride, bromide, or iodide ions.
Type:
Grant
Filed:
May 24, 1983
Date of Patent:
November 17, 1987
Assignee:
Cetus Corporation
Inventors:
Jennie C. Hunter, Angela Belt, Lynn S. Sotos, Michelle E. Fonda
Abstract: The present invention discloses permanent establishment of an immortal line of fetal glial cells. The fetal glial cell line is capable of mitotically proliferating and continually growing in vitro under suitable culture media and environmental conditions. A method of producing immortalized human fetal glial cell line is also disclosed. The method comprises transfecting primary human fetal glial cells with an origin-defective mutant of SV40 virus, passaging the resulting astroglial cells through suitable number of cycles and obtaining the desired cell line. The cell line of the present invention is capable of supporting multiplication of JC virus.
Type:
Grant
Filed:
October 4, 1984
Date of Patent:
November 17, 1987
Assignee:
The United States of America as represented by the Department of Health and Human Services
Abstract: A method of producing a non-heme haloperoxidase which is substantially resistant to inactivation, at room temperature, in up to 0.3M H.sub.2 O.sub.2 for up to 25 hours, and up to 0.5 mM HOCl for up to two minutes. One such haloperoxidase, isolated from Curvularia inaequalis, contains about 2 gram atoms of zinc per molecule. A halogenation reaction employing the enzyme can be performed at H.sub.2 O.sub.2 and hypohalous acid concentrations which produce rapid inactivation of heme-containing haloperoxidases.
Type:
Grant
Filed:
May 24, 1983
Date of Patent:
November 17, 1987
Assignee:
Cetus Corporation
Inventors:
John Geigert, Te-Ning E. Liu, Thabiso N'timkulu
Abstract: A novel recombinant DNA containing the base sequence shown in FIG. 1 or a portion thereof which exhibits promoter activity. The base sequence exhibiting a potent promoter activity is obtained from the chromosomal DNA of strain Bacillus by, for example, cloning with a cloning vector. By growing a transformant of Bacillus transformed with the recombinant DNA carrying a peptide encoding nucleotide, the desired peptide may be produced.
Abstract: A method for preparation of multimeric fibronectin. Dimeric fibronectin is treated with guanidine. The dimeric fibronectin so treated is then incubated to allow multimeric fibronectin to form therefrom.
Abstract: The invention relates to pharmaceutical compositions for use in the therapy of pathological states related to disturbances of the nervous stimulus in the central (CNS) and peripheral (PNS) nervous system containing as an active substance the cytidine monophosphate of 5-acetamido-3,5-dideoxy-D-glycero-D-galactononulosaminic acid. Moreover the invention relates to an improved method for preparing said compound by the condensation of cytidine triphosphate (CTP) with N-acetylneuraminic acid (NANA), catalyzed by the enzyme CMP-transferase (CMP-acylneuraminate synthase) (EC 2.7.7.43).
Abstract: Plasmid vectors and a process for the preparation thereof are disclosed having the same replication region as pBR322, but which have a substantially higher copy number per cell. The plasmid vectors contain a G.fwdarw.T point mutation at base pair 3074 of the pBR322 sequence which holds back synthesis of the repressor of plasmid replication, and also contain either no tetracycline resistance gene or the tetracycline resistance gene in an inactivated or weakened state.
Type:
Grant
Filed:
September 17, 1984
Date of Patent:
October 27, 1987
Assignee:
Richter Gedeon Vegyeszeti Gyar R.T.
Inventors:
Imre Boros, Pal Venetianer, Gyorgy Posfai
Abstract: An expression vector carrying a gene coding for a phosphate-binding protein has been found to have a strong gene expression. The expression vector can be produced by transforming a bacterium belonging to Enterobacteriaceae with a recombinant vector carrying a DNA fragment containing a gene coding for a phosphate-binding protein to form transformants, selecting the transformants containing the desired recombinant vector from said transformants, and isolating the desired recombinant vector from the selected transformants. The expression vector is useful for producing polypeptides.
Type:
Grant
Filed:
June 6, 1983
Date of Patent:
October 27, 1987
Assignee:
The Research Foundation for Microbial Diseases of Osaka University
Abstract: By coupling an antigen to a polyphenol derivative the formation of the corresponding antibody can be selectively suppressed by administration thereof to the desired subject.
Type:
Grant
Filed:
August 9, 1983
Date of Patent:
October 27, 1987
Assignee:
Cornell Research Foundation, Inc.
Inventors:
Carl G. Becker, Tova Francus, Gregory W. Siskind
Abstract: A hybridoma which produces monoclonal antibodies having a high affinity and selectivity for digoxin is produced by immunizing mice with digoxin, fusing the spleen cells from the treated mice with mice myeloma cells, separating hybrids from non-fused cells, selecting the hybrids which produce monoclonal antibodies directed against digoxin and isolating the hybrids.
Abstract: B-cell neoplasm is detected by hybridizing lymphocytic DNA with DNA probes that identify chromosomal translocations between human chromosomes 11 and 18.
Abstract: An enzyme preparation having specific bilirubin degrading activity is described. The enzymes useful therein are obtained from various higher plant sources of the families Solanaceae, Musaceae and Liliaceae. Specific plant sources include eggplants, tomatoes and potatoes from the Solanaceae family, bananas from the Musaceae family, and onions from the Liliaceae family. Assay compositions, analytical elements and methods for use of such are also described.
Abstract: New angiogenic factors of low molecular weight (under 1000), useful as treatment agents for wound healing and for biological assaying, made from in vitro cultures of a wide variety of tumor cells by a treatment which breaks up the proteinaceous tumor angiogenesis factors ("TAF") in them and liberates the more mobile low molecular weight factors. The treatment can be applied to cell extracts or the aqueous portion of the culture, and the proteinaceous part may be rendered insoluble or captured chemically so as to release the new factor. Separation techniques which can be used include solvent extraction of dried liquid fractions, using polar solvents such as ethanol, and the liberated factor can be purified chromatographically using adsorbents for which the factor has affinity, especially a basic adsorbent and preferably polysaccharide-based, followed by elution.
Type:
Grant
Filed:
November 29, 1983
Date of Patent:
October 6, 1987
Inventors:
Jacqueline B. Weiss, Christopher R. Hill
Abstract: Polysaccharides are produced by single stage continuous culture of Xanthomonas bacteria, especially of the Xanthomonas campestris group in a chemically-defined culture medium. Cultures have been run for over 2,000 hours without reduction in the polysaccharide yield. The physical and chemical properties of the product can be controlled by selection of the growth limiting substrate (limiting nutrilite) in the culture medium to give a range of polysaccharides suitable for various applications.
Type:
Grant
Filed:
June 6, 1984
Date of Patent:
September 29, 1987
Assignee:
The Secretary of State for Defence in Her Majesty's Government of the United Kingdon of Great Britain and Northern Ireland
Inventors:
Derek C. Ellwood, Charles G. T. Evans, Richard G. Yeo
Abstract: Plasmid vectors are provided that carry complementary DNA (cDNA) clones coding for polypeptides exhibiting mammalian multi-lineage growth cell activity. One of these polypeptides is 166 amino acids in length, including a potential leader sequence of about 19 amino acids. The cDNA is derived from messenger RNA isolated from a mouse T-cell line after activation with concanavalin A. The cDNA was cloned by incorporation into a plasmid vector, which was then transformed into E. coli. The plasmid vector also contains DNA segments from the SV40 virus, permitting expression of the cDNA after transfection into a mammalian host cell, such as monkey COS-7 cells.
Type:
Grant
Filed:
March 19, 1984
Date of Patent:
September 22, 1987
Assignee:
DNAX Research Institute of Molecular and Cellular Biology, Inc.
Inventors:
Takashi Yokota, Frank Lee, Donna Rennick, Ken-ichi Arai